The Centre on Wednesday said that the Maharashtra-owned Haffkine Biopharmaceutical Corp will produce 228 million Covaxin doses per annum as part of a technology transfer arrangement with vaccine maker Bharat Biotech , a move that will increase the number of Covid-19 vaccines produced locally. It said this was apart from Bharat Biotech’s own efforts to enhance Covaxin production to 100 million doses per month by October. Serum Institute is also ramping up Covishield production from 65 million to 110 million doses per month. India administered an average of 1.93 million doses of vaccine a day in May. The vaccine production process involves two stages – drug substance and final drug product.

Source: Hindustan Times June 02, 2021 10:50 UTC